Data as of Q4 2025 (Dec 31, 2025)
DAWN

DAY ONE BIOPHARMACEUTICALS I

Institutional Ownership ยท Q4 2025

Filing: Q4 2025

DAY ONE BIOPHARMACEUTICALS I (DAWN) is held by 175 institutional investors with combined holdings of $2.6B. Major holders include Stonepine Capital Managem, BlackRock, Inc. (BLK), Atlas Venture Life Scienc.

Institutional Holders
175
Total Value
$2.6B
Ownership %
75.5%